Atrial septal defect (ASD) device trans-catheter closure: limitations

J Thorac Dis. 2018 Sep;10(Suppl 24):S2923-S2930. doi: 10.21037/jtd.2018.07.128.

Abstract

Transcatheter closure is a widespread technique used to treat secundum atrial septal defects (ASDs). When compared to surgery, it provides a less invasive approach with quicker recovery and reduced physical and psychological impact. Nowadays, almost 85-90% of all secundum ASD can be closed by using a transcatheter approach. However, several limitations may have a significant impact on the feasibility and success of percutaneous ASD closure. Limitations can be grouped as: (I) anatomical; (II) device-related; (III) associated defects and natural history associated issues; (IV) physiological; (V) complications. Physician should be aware of potential limits of percutaneous ASD closure.

Keywords: Heart septal defect; atrial; interventional cardiology; septal occlude device.

Publication types

  • Review